[1] Villemagne V. L., Burnham S., Bourgeat P., Brown B., Ellis K. A., Salvado O., Szoeke C., Macaulay S. L., Martins R., Maruff P., Ames D., Rowe C. C., Masters C. L., Australian Imaging Biomarkers, Lifestyle Research Group (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 12, 357-367.
[2] Sperling R., Mormino E., Johnson K. (2014) The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron 84, 608-622.
[3] Jack C. R., Jr., Knopman D. S., Jagust W. J., Petersen R. C., Weiner M. W., Aisen P. S., Shaw L. M., Vemuri P., Wiste H. J., Weigand S. D., Lesnick T. G., Pankratz V. S., Donohue M. C., Trojanowski J. Q. (2013) Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12, 207-216.
[4] Myers N., Pasquini L., Gottler J., Grimmer T., Koch K., Ortner M., Neitzel J., Muhlau M., Forster S., Kurz A., Forstl H., Zimmer C., Wohlschlager A. M., Riedl V., Drzezga A., Sorg C. (2014) Within-patient correspondence of amyloid-beta and intrinsic network connectivity in Alzheimer's disease. Brain 137, 2052-2064.
[5] Jack C. R., Jr., Bennett D. A., Blennow K., Carrillo M. C., Dunn B., Haeberlein S. B., Holtzman D. M., Jagust W., Jessen F., Karlawish J., Liu E., Molinuevo J. L., Montine T., Phelps C., Rankin K. P., Rowe C. C., Scheltens P., Siemers E., Snyder H. M., Sperling R., Contributors (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement 14, 535-562.
[6] Heilbronner SR Haber SN (2014) Frontal cortical and subcortical projections provide a basis for segmenting the cingulum bundle: implications for neuroimaging and psychiatric disorders. J Neurosci 34, 10041-10054.
[7] Tardif CL Devenyi GA, Amaral RSC, Pelleieux S, Poirier J, Rosa-Neto P, Breitner J, Chakravarty MM; PREVENT-AD Research Group (2018) Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease. Hum Brain Mapp 39, 971-984.
[8] Wang L., Fagan, A. M., Shah, A. R., Beg, M. F., Csernansky, J. G., Morris, J. C., & Holtzman, D. M (2012) Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer type. Alzheimer Disease & Associated Disorders 26, 314–321.
[9] Ahmed Z Cooper J, Murray TK, Garn K, McNaughton E, Clarke H, Parhizkar S, Ward MA, Cavallini A, Jackson S, Bose S, Clavaguera F, Tolnay M, Lavenir I, Goedert M, Hutton ML, O'Neill MJ (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathologica 127, 667-683.
[10] Braak H Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica 82, 239–259.
[11] Braak H Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16, 271–278.
[12] Jacobs HIL Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KA (2018) Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci 21, 424-431.
[13] Lee SH Coutu JP, Wilkens P, Yendiki A, Rosas HD, Salat DH; Alzheimer’s disease Neuroimaging Initiative (ADNI) (2015) Tract-based analysis of white matter degeneration in Alzheimer's disease. Neuroscience 301, 79-89.
[14] Catani M., & De Schotten, M. T (2008) A diffusion tensor imaging tractography atlas for virtual in vivo dissections. Cortex 44, 1105–1132.
[15] Hua K., Zhang, J., Wakana, S., Jiang, H., Li, X., Reich, D. S., Calabresi, P. A., Pekar, J. J., van Zijl, P. C., & Mori, S (2008) Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. NeuroImage 39, 336–347.
[16] Lin Y. C., Shih, Y. C., Tseng, W. Y., Chu, Y. H., Wu, M. T., Chen, T. F., Tang, P. F., & Chiu, M. J (2014) Cingulum correlates of cognitive functions in patients with mild cognitive impairment and early Alzheimer’s disease: a diffusion spectrum imaging study. Brain Topography 27, 393–402.
[17] Yendiki A Panneck P, Srinivasan P, Stevens A, Zöllei L, Augustinack J, Wang R, Salat D, Ehrlich S, Behrens T, Jbabdi S, Gollub R, Fischl B (2011) Automated probabilistic reconstruction of white-matter pathways in health and disease using an atlas of the underlying anatomy. Front Neuroinform 5, 23.
[18] Watanabe A Nakamae T, Sakai Y, Nishida S, Abe Y, Yamada K, Yokota I, Narumoto J (2018) The detection of white matter alterations in obsessive-compulsive disorder revealed by TRActs Constrained by UnderLying Anatomy (TRACULA). Neuropsychiatr Dis Treat 14, 1635-1643.
[19] Pietracupa S Suppa A, Upadhyay N, Giannì C, Grillea G, Leodori G, Modugno N, Di Biasio F, Zampogna A, Colonnese C, Berardelli A, Pantano P (2018) Freezing of gait in Parkinson's disease: gray and white matter abnormalities. J Neurol 265, 52-62.
[20] O'Bryant SE Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R; Texas Alzheimer's Research Consortium (2008) Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol 65, 1091-1095.
[21] Geffen GM Butterworth P, Geffen LB (1994) Test-retest reliability of a new form of the auditory verbal learning test (AVLT). Arch Clin Neuropsychol 9, 303-316.
[22] Moradi E Hallikainen I, Hänninen T, Tohka J; Alzheimer's Disease Neuroimaging Initiative (2016) Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease. Neuroimage Clin 13, 415-427.
[23] Shaw L. M., Vanderstichele H., Knapik-Czajka M., Clark C. M., Aisen P. S., Petersen R. C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W., Lee V. M., Trojanowski J. Q., Alzheimer's Disease Neuroimaging Initiative (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65, 403-413.
[24] De Meyer G., Shapiro F., Vanderstichele H., Vanmechelen E., Engelborghs S., De Deyn P. P., Coart E., Hansson O., Minthon L., Zetterberg H., Blennow K., Shaw L., Trojanowski J. Q., Alzheimer's Disease Neuroimaging Initiative (2010) Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol 67, 949-956.
[25] Jack C. R., Jr., Knopman D. S., Chetelat G., Dickson D., Fagan A. M., Frisoni G. B., Jagust W., Mormino E. C., Petersen R. C., Sperling R. A., van der Flier W. M., Villemagne V. L., Visser P. J., Vos S. J. (2016) Suspected non-Alzheimer disease pathophysiology--concept and controversy. Nat Rev Neurol 12, 117-124.
[26] Dale AM Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179-194.
[27] Fischl B Sereno MI, Tootell RB, Dale AM (1999) High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 8, 272-284.
[28] Iglesias JE Sabuncu MR, Van Leemput K; Alzheimer's Disease Neuroimaging Initiative (2012) Incorporating parameter uncertainty in Bayesian segmentation models: application to hippocampal subfield volumetry. Med Image Comput Comput Assist Interv 15, 50-57.
[29] Yendiki A Koldewyn K, Kakunoori S, Kanwisher N, Fischl B (2014) Spurious group differences due to head motion in a diffusion MRI study. Neuroimage 88, 79-90.
[30] Behrens TE Berg HJ, Jbabdi S, Rushworth MF, Woolrich MW (2007) Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? Neuroimage 34, 144-155.
[31] Von Der Heide RJ Skipper LM, Klobusicky E, Olson IR (2013) Dissecting the uncinate fasciculus: disorders, controversies and a hypothesis. Brain 136, 1692-1707.
[32] Rimol LM Botellero VL, Bjuland KJ, Løhaugen GCC, Lydersen S, Evensen KAI, Brubakk AM, Eikenes L, Indredavik MS, Martinussen M, Yendiki A, Håberg AK, Skranes J (2019) Reduced white matter fractional anisotropy mediates cortical thickening in adults born preterm with very low birthweight. Neuroimage 188, 217-227.
[33] Delli Pizzi S Franciotti R Taylor JP, Esposito R, Tartaro A, Thomas A, Onofrj M, Bonanni L (2015) Structural Connectivity is Differently Altered in Dementia with Lewy Body and Alzheimer's Disease. Front Aging Neurosci 7, 208.
[34] Amaral R.S., Park, M.T., Devenyi, G.A., Lynn, V., Pipitone, J., Winterburn, J., . . . Alzheimer’s Disease Neuroimaging, I (2016) Manual segmentation of the fornix, fimbria, and alveus on high-resolution 3T MRI: Application via fully-automated mapping of the human memory circuit white and grey matter in healthy and pathological aging. Neuroimage.
[35] Fortea J Vilaplana E, Alcolea D, Carmona-Iragui M, Sánchez-Saudinos MB, Sala I, Antón-Aguirre S, González S, Medrano S, Pegueroles J, Morenas E, Clarimón J, Blesa R, Lleó A; Alzheimer's Disease Neuroimaging Initiative (2014) Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. Ann Neurol 76, 223-230.
[36] Sjöbeck M Haglund M, Englund E (2006) White matter mapping in Alzheimer's disease: A neuropathological study. Neurobiol Aging 27, 673-680.
[37] Kantarci K., Murray M. E., Schwarz C. G., Reid R. I., Przybelski S. A., Lesnick T., Zuk S. M., Raman M. R., Senjem M. L., Gunter J. L., Boeve B. F., Knopman D. S., Parisi J. E., Petersen R. C., Jack C. R., Jr., Dickson D. W. (2017) White-matter integrity on DTI and the pathologic staging of Alzheimer's disease. Neurobiol Aging 56, 172-179.
[38] Kantarci K Schwarz CG, Reid RI, Przybelski SA, Lesnick TG, Zuk SM, Senjem ML, Gunter JL, Lowe V, Machulda MM, Knopman DS, Petersen RC, Jack CR Jr (2014) White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration. JAMA Neurol 71, 1547-1554.
[39] Cavanna AE Trimble MR. (2006) The precuneus: a review of its functional anatomy and behavioural correlates. Brain 129, 564-583.
[40] SA Back (2014) Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management. Clin Perinatol 41, 1-24.